Bratt, Alison M., Masanyero-Bennie, Bernadette, Kelley, Stephen P. (2017) A meta-analytical assessment of the efficacy of immediate release methylphenidate to reduce hyperactivity in children with autistic spectrum disorder (ASD). Journal of Pharmaceutical Sciences & Experimental Pharmacology, 1 (1). pp. 10-18. (KAR id:65038)
|
PDF
Publisher pdf
Language: English |
|
|
Download (604kB)
Preview
|
Preview |
|
This file may not be suitable for users of assistive technology.
Request an accessible format
|
|
| Official URL https://norcaloa.com/PSEP/article-in-press/PSEP-10... |
|
Abstract
Psychostimulant medications, such as Methylphenidate (MPH) have become main stay treatments for Attention Deficit
This study performed a meta-analysis of three randomized controlled trials homogeneously measuring the effect of immediate release Methylphenidate (MPH) to reduce scores of hyperactivity in children with comorbid ADHD + ASD. The findings that IR-MPH produces an overall moderate significant benefit to reduce hyperactivity in ASD are discussed in relation to the risk/benefit question of medication use in this population.
| Item Type: | Article |
|---|---|
| Subjects: | Q Science |
| Divisions: | Divisions > Division of Natural Sciences > Medway School of Pharmacy |
| Depositing User: | Alison Kelley |
| Date Deposited: | 06 Dec 2017 15:57 UTC |
| Last Modified: | 16 Feb 2021 13:51 UTC |
| Resource URI: | https://kar.kent.ac.uk/id/eprint/65038 (The current URI for this page, for reference purposes) |
- Link to SensusAccess
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):
Download Statistics
Download Statistics
